Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Amber Rogers

1PUBLICATIONS

19CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 19, 2025

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Maise Al Bakir, James L Reading, Samuel Gamble

Pageof 1

Frequent Collaborators

1 joint publications

Maise Al Bakir

1 joint publications

James L Reading

1 joint publications

Sophia Ward

1 joint publications

Carlos Martínez-Ruiz

1 joint publications

Clare Puttick

1 joint publications

Ariana Huebner

1 joint publications

Daniel E Cook

1 joint publications

David A Moore

1 joint publications

Cristina Naceur-Lombardelli

1 joint publications

Felipe Gálvez-Cancino

Frequent Collaborators

1 joint publications

Maise Al Bakir

1 joint publications

James L Reading

1 joint publications

Sophia Ward

1 joint publications

Carlos Martínez-Ruiz

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos